Krystal Biotech Inc (KRYS) — Technical state
As of 2026-10-30 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Closelooknet score: 61 out of 100 (momentum 67 · quality 85 · valuation 19), as of 2026-11-01.
- Signal: Pullback inside an uptrend stack — Trades -1.5% vs the 50-day and +7.7% vs the 200-day average, 13.1% below the 52-week high and +80.6% off the 52-week low. Computed from daily closes. (as of 2026-10-30)
- Trend: Krystal Biotech Inc trades 1.5% below its 50-day and 7.7% above its 200-day moving average. (as of 2026-10-30)
Krystal Biotech is a commercial-stage biotechnology company that develops and sells genetic medicines for diseases with few existing treatments. Its approved product, VYJUVEK, treats a rare skin disorder called dystrophic epidermolysis bullosa.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the KRYS overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.
Trades -1.5% vs the 50-day and +7.7% vs the 200-day average, 13.1% below the 52-week high and +80.6% off the 52-week low. Computed from daily closes.
The moving-average stack
- vs 20-day+2.4%
- vs 50-day-1.5%
- vs 200-day+7.7%
- 52-week band13.1% off the high · +80.6% off the low
- Streak5 consecutive up sessions
- 50-day crossprice crossed down through the 50-day 24 sessions ago
- Stochastic%K 77.4 · %D 42.9
Continue: the KRYS chart & overview · quality & forensics · the earnings record · the signal board
FAQ · from the current data · as of 2026-10-30
Quick answers
What is the current Closelooknet signal on KRYS?
Pullback inside an uptrend stack — Trades -1.5% vs the 50-day and +7.7% vs the 200-day average, 13.1% below the 52-week high and +80.6% off the 52-week low. Computed from daily closes. As of 2026-10-30; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is KRYS above its 50-day and 200-day moving averages?
As of 2026-10-30, Krystal Biotech Inc trades -1.5% below its 50-day and +7.7% above its 200-day average, with the 20-day +2.4% away.
How far is KRYS from its 52-week high?
13.1% below the 52-week high and 80.6% above the 52-week low, as of 2026-10-30.
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- BION.SW BB Biotech AGindustry
- HALO Halozyme Therapeutics Incindustry
- ONC BeiGene, Ltd.industry
- UCB.BR UCB SAindustry
- ARGX.BR Argen-Xindustry
- ARGX argenx NV ADRindustry
- KOD Kodiak Sciences Incindustry
- REPL Replimune Group Incindustry
- MRNA Moderna Incindustry
- ARQT Arcutis Biotherapeutics Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- ABSI Absci Corpindustry
- EXEL Exelixis Incindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- XNCR Xencor Incindustry
- ALK-B.CO ALK-Abelló A/Sindustry
- ADMA ADMA Biologics Incindustry
- VRDN Viridian Therapeutics Incindustry
- IRON Disc Medicine Inc.industry
- BHVN Biohaven Ltd.industry